Medipower (Overseas) Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Medipower (Overseas) şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

Geri Alım Getirisi

Toplam Hissedar Getirisi	0%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	₪0.140
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Solid Earnings Reflect Medipower (Overseas)'s (TLV:MDPR) Strength As A Business

Mar 29

Medipower (Overseas) Public Co. Limited's (TLV:MDPR) Business Is Yet to Catch Up With Its Share Price

Jan 31

A Look At The Intrinsic Value Of Medipower (Overseas) Public Co. Limited (TLV:MDPR)

May 06

If You Had Bought Medipower (Overseas) (TLV:MDPR) Stock Three Years Ago, You Could Pocket A 25% Gain Today

Jan 25

With A 4.7% Return On Equity, Is Medipower (Overseas) Public Co. Limited (TLV:MDPR) A Quality Stock?

Dec 16

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: MDPR şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: MDPR şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Medipower (Overseas) Piyasaya Karşı Temettü Getirisi

MDPR temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (MDPR)	0%
Pazarın Alt %25'i (IL)	2.2%
Pazarın En İyi %25'i (IL)	6.3%
Sektör Ortalaması (Real Estate)	2.8%
Analist tahmini (MDPR) (3 yıla kadar)	n/a

Önemli Temettü: MDPR şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, MDPR şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: MDPR IL piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: MDPR herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Medipower (Overseas) Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Third quarter 2024 earnings released: EPS: US$0.043 (vs US$0.044 in 3Q 2023)

Second quarter 2024 earnings released: EPS: US$0.051 (vs US$0.056 in 2Q 2023)

First quarter 2024 earnings released: EPS: US$0.048 (vs US$0.045 in 1Q 2023)

Solid Earnings Reflect Medipower (Overseas)'s (TLV:MDPR) Strength As A Business

Medipower (Overseas) Public Co. Limited to Report Q4, 2023 Results on Mar 26, 2024

Full year 2023 earnings released: EPS: US$0.16 (vs US$0.026 in FY 2022)

Medipower (Overseas) Public Co. Limited, Annual General Meeting, Apr 30, 2024

Medipower (Overseas) Public Co. Limited, Annual General Meeting, Apr 30, 2024

Now 20% undervalued

Medipower (Overseas) Public Co. Limited's (TLV:MDPR) Business Is Yet to Catch Up With Its Share Price

Third quarter 2023 earnings released: EPS: US$0.044 (vs US$0.048 in 3Q 2022)

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

Second quarter 2023 earnings released: EPS: US$0.056 (vs US$0.087 in 2Q 2022)

Now 21% undervalued after recent price drop

Now 20% undervalued

Now 20% undervalued

Investor sentiment deteriorates as stock falls 19%

Now 26% undervalued after recent price drop

First quarter 2023 earnings released: EPS: US$0.045 (vs US$0.033 loss in 1Q 2022)

Investor sentiment improves as stock rises 17%

Full year 2022 earnings released: EPS: US$0.026 (vs US$0.22 in FY 2021)

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: US$0.048 (vs US$0.001 loss in 3Q 2021)

Insufficient new directors

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: US$0.087 (vs US$0.012 in 2Q 2021)

First quarter 2022 earnings released: US$0.033 loss per share (vs US$0.055 profit in 1Q 2021)

Insufficient new directors

Full year 2021 earnings released: EPS: US$0.22 (vs US$0.066 in FY 2020)

Insufficient new directors

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2021 earnings released: EPS US$0.012 (vs US$0.018 in 2Q 2020)

First quarter 2021 earnings released: EPS US$0.055 (vs US$0.022 in 1Q 2020)

A Look At The Intrinsic Value Of Medipower (Overseas) Public Co. Limited (TLV:MDPR)

Full year 2020 earnings released

New 90-day low: ₪5.76

If You Had Bought Medipower (Overseas) (TLV:MDPR) Stock Three Years Ago, You Could Pocket A 25% Gain Today

With A 4.7% Return On Equity, Is Medipower (Overseas) Public Co. Limited (TLV:MDPR) A Quality Stock?

New 90-day high: ₪6.20

Third quarter 2020 earnings released: EPS US$0.029

New 90-day high: ₪5.43

Earnings released

New 90-day high - ₪5.00

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin